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Abstract 
Background Context 
Adipokines are secreted by white adipose tissue and have been associated with fracture healing. Our 
goal was to report the temporal expression of adipokines during spinal fusion in an established rabbit 
model. 
Purpose 
Our goal was to report the temporal expression of adipokines during spinal fusion in an established 
rabbit model. 
Study Design 
The study design included a laboratory animal model. 
Methods 
New Zealand white rabbits were assigned to either sham surgery (n=2), unilateral posterior spinal fusion 
(n=14), or bilateral posterior spinal fusion (n=14). Rabbits were euthanized 1–6 and 10 weeks out from 
surgery. Fusion was evaluated by radiographs, manual palpation, and histology. Reverse transcription-
polymerase chain reaction on the bone fusion mass catalogued the gene expression of leptin, 
adiponectin, resistin, and vascular endothelial growth factor (VEGF) at each time point. Results were 
normalized to the internal control gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (2^ΔCt), 
and control bone sites (2^ΔΔCt). Quantitative data were analyzed by two-factor analysis of variance 
(p<.05). 
Results 
Manual palpation scores, radiograph scores, and histologic findings showed progression of boney fusion 
over time (p<.0003). The frequency of fusion by palpation after 4 weeks was 68.75%. Leptin expression 
in decortication and bone graft sites peaked at 5 weeks after the fusion procedure (p=.0143), 
adiponectin expression was greatest 1 week after surgery (p<.001), VEGF expression peaked at 4 weeks 
just after initial increases in leptin expression (p<.001), and resistin decreased precipitously 1 week after 
the fusion procedure (p<.001). 
Conclusions 
Leptin expression is likely associated with the maturation phase of bone fusion. Adiponectin and resistin 
may play a role early on during the fusion process. Our results suggest that leptin expression may be 
upstream of VEGF expression during spinal fusion, and both appear to play an important role in bone 
spinal fusion. 
Keywords 
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Introduction 
Obesity creates a low-grade inflammatory state that affects the pathophysiology of numerous 
diseases.1,2,3 Obesity has been implicated in the delay of bone healing after a fracture, osteoarthritis, and 
rheumatoid arthritis.4,5,6,7,8,9,10,11 There is evidence that obesity negatively affects bone physiology.12,13,14 
Understanding the biochemical pathways that govern the relationship between obesity and bone 
metabolism is vital for understanding the efficacy of orthopedic interventions for bone healing. 
Adipokines are a group of cytokines produced by white adipose tissues that play a role in the low-grade 
inflammatory state associated with obesity.15,16 Adipokines include leptin, resistin, visfatin, adiponectin, 
and others.17 The role of adipokines on the risk of fracture and fracture healing is influenced by the type 
of adipokine as well the amount of adipokine present both locally and systematically.18,19,20,21 Leptin has 
been implicated in fracture healing in a mouse model.11 Leptin receptors have been found on 
osteoblasts, implicating its role in bone mineralization, and there is evidence that leptin is vital during 
callous formation for fracture healing.11,22,23 Leptin upregulates vascular endothelial growth factor 
(VEGF) in cancer cells, and there is research showing the role of VEGF in early vascularization, which 
precedes bone formation.24,25,26,27 These processes and growth factors are necessary for spinal fusion.28 
The spinal fusion process involves a balance of chemical signals promoting bone formation that is 
needed to span the distances between vertebrae. Based on the role of adipokines in bone formation, 
adipokines may be essential for the formation of a fusion mass. Khan et al. have identified leptin's role in 
organized callous fracture healing using a leptin knockout mouse model.11 The authors concluded that 
leptin was critical to fracture callous formation. Our group hypothesized that leptin and other 
adipokines play a pivotal role in a rabbit spine fusion model. We selected a well-established rabbit spine 
fusion model and modified the design to provide controls for general anesthesia, as well as the local 
effects of surgical approach on soft-tissue injury.29,30 Our specific objectives were to identify the gene 
expression profile of adipokines during the spinal fusion process and to determine the temporal and 
relative relationship of adipokine expression. We hypothesized that the gene expression of leptin, 
adiponectin, VEGF, and resistin would be greater than, and specific to, the generation of bone callus 
necessary for spinal fusion. 
Materials and methods 
All experiments were conducted following approval by our Institutional Animal Care and Use 
Committee. Thirty 1-year old New Zealand white rabbits were included. The area around the right and 
left transverse processes at L5 and L6 were used as points of evaluation. The rabbits were divided into 
three groups. The first group was two control rabbits that were anesthetized and had a sham skin 
incision with muscular dissection. These rabbits were the control for the surgical procedures. The 
second group consisted of 14 rabbits that received the same surgical approach to both L5 and L6 sites, 
but one side received an interpositional fat graft to prevent spinal fusion, and the contralateral site 
received transverse process decortication and iliac crest autograft application anticipated to form a 
bony fusion (unilateral fusion [UL] rabbits). Group 3 consisted of 14 rabbits, which received bilateral 
decortication and iliac crest autograft (bilateral fusion [BL] rabbits). Four rabbits (2 from UL group and 2 
from BL group) were euthanized at 1, 2, 3, 4, 5, 6, and 10 weeks after their procedure (Fig. 1). The bone 
from the non-decorticated transverse processes within the UL group was used as a control for the bone 
fusion surgical procedure, including for autografting and loss of mobility of the spine. The control rabbits 
were euthanized at 2 weeks after their sham surgery. Our groups were designed to control for the 
influence of general anesthesia, surgical approach, and the effect of UL and motion to the expression 
pattern of adipokines during spinal fusion. All surgical procedures were performed together with 
surgeons with doctor of medicine and doctor of veterinary medicine degrees. 
 Fig. 1. Illustration of the experimental design. 
Radiographic scores 
Immediately after euthanasia, dorsal-ventral and lateral digital radiographs of the lumbar spine were 
obtained from four rabbits (two from the BL group and two from the UL group) at the 2-, 4-, 6-, and 10-
week time points to assess the fusion mass. As in previous studies, the radiographs were graded as 
either 1 (unfused), 2 (partially fused), or 3 (completely fused).31 The radiographic scoring was performed 
by one researcher to reduce variability. 
Manual palpation 
The fusion mass at the level of interest was assessed using manual palpation. Motion with flexion-
extension at the level of interest was compared with motion with flexion-extension at adjacent levels.29 
The manual palpation examination was scored using a quantitative system from 0 (no fusion) to 4 
(complete fusion), similar to that previously published32,33,34 (1=minimal, 2=mild, 3=moderate reduction 
of motion, and 4=marked or no movement at the level of interest compared with the adjacent levels). A 
complete fusion was defined as 4 out of 4 on the previously mentioned scale at least 4 weeks out from 
surgery.35 Surgeons with a doctor of medicine degree and surgeons with doctor of veterinary medicine 
degree performed the palpation examination together, and the documented score was agreed upon by 
all researchers. 
RNA extraction, cDNA synthesis, and quantitative reverse transcription-polymerase 
chain reaction 
After manual palpation, a representative portion of the medial fusion mass in both Groups 2 and 3 (UL 
and BL) was harvested for RNA extraction and gene analysis. The samples were extracted using a 
sterilized rongeur. The fusion specimens were snap-frozen in liquid nitrogen and placed at −80°C. 
Additionally, normal transverse process bone specimens were harvested from two levels cephalad to 
the level of interest and were maintained as separate specimens. The total RNA was extracted using the 
guanidinium thiocyanate-phenol-chloroform extraction method (TRIzol and chloroform, Invitrogen, 
Carlsbad, CA, USA) and frozen bone specimens were pulverized in liquid nitrogen. The total RNA was 
then isolated using standard procedures.36 Primers were designed and verified using the National Center 
for Biotechnology Information's Primer-BLAST (Table). Each primer pair was optimized on a heat 
gradient to ensure amplification efficiency of around 95%–100%. All reactions were run in triplicate for 
each target gene. The data for the four target genes were presented as mean±standard error of the 
mean relative mRNA expression normalized to the internal control gene, glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) (2^ΔCt). This is a standard technique to analyze the relative expression of a 
gene as well as to assist as an internal quality control for the polymerase chain reaction (PCR) 
analysis.37,38 The four target gene expressions were standardized to independent biological replicate 
sites (n=4 samples) from the control surgery group using the 2^(ΔΔCt) method to elucidate mean fold 
changes in gene expression. Relative expression levels were obtained by normalization to GAPDH by the 
comparative 2^ΔCt method.39 This was performed for both bone from the fusion mass and bone from 
the non-fused transverse processes in the UL group. These results were plotted on the same graph to 
illustrate differences in expression attributable to the fusion process. Of note, both 18s ribosomal RNA 
(18s rRNA) and beta-actin mRNA were tested as potential housekeeping genes during our experiment. 
Neither 18s rRNA nor beta-actin mRNA provided accurate levels of gene expression when several 
different primer sequences were tested. 
Table. Primer sequences for New Zealand white rabbits 
Forward primer (5′–3′) Reverse primer (5′–3′) 
 
Leptin GCGGAAAGTCCAGGATGACA CAGGGATGAAGTCCAAACCGA 
Adiponectin AGAGATGGAACCCCTGGTGA GCTGAATGCTGAGCGGTAGA 
Resistin CACTGTGTCCGGTGGATGAT CAGGTTCAGGCTCCTCGTTC 
VEGF-A GGCTGCTGCAATGATGAAAG GTGCTGTAGGAAGCTCATCTC 
GAPDH AGACACGATGGTGAAGGTCG TGCCGTGGGTGGAATCATAC 
VEGF-A, vascular endothelial growth factor A; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. 
Histology 
The treated levels were dissected from the rabbit spine, placed in 10% buffered formalin, and 
subsequently decalcified. Serial sections were stained with Mallory aniline blue (MAB) tissue stain as 
well as routine hematoxylin and eosin. Sections were evaluated for evidence of fusion, tissue within the 
intertransverse process space, and bony remodeling. 
Data and statistical analysis 
All quantitative data (reverse transcription-polymerase chain reaction [RT-PCR] results, radiographic 
scores, and palpation scores) were analyzed by a repeated two-way analysis of variance to compare 
among groups and across time to study the effects of surgical model standardization (ie, UL vs. BL) and 
time from surgery. The significance level of 0.05 was used in all statistical comparisons. All statistical 
analyses were performed with SPSS software (SPSS Inc., Chicago, IL, USA). Relative quantitation of 
leptin, adiponectin, resistin, and VEGF gene expression using real-time quantitative PCR was calculated 
by the subtraction of the threshold cycle number of the target gene from the internal control reference 
gene, GAPDH, expressed as the power of 2 (2^ΔCt). Additionally, the 2^ΔCt of the target gene was 
expressed as a ratio to control rabbit 2^ΔCt (ΔΔCt).39 
Results 
All rabbits completed the study and all data were collected as per protocol. The average body weight of 
rabbits was 3.53 (±0.38) kg. 
Manual palpation scores for rabbits in the UL and BL groups significantly increased with time (duration 
since surgery) (p<.0001, Fig. 2). Although not statistically significant (p=.11), there was a trend toward 
lower palpation scores (more motion) in UL spines. Both radiographic and manual palpation scores 
indicated spine fusion at the Week 5–6 time period. Fusion frequency at 4–10 weeks after surgery was 
68.75% (11 of the 16 rabbits). This result did not significantly differ by fusion type as 62.5% (5/8) were 
fused in the UL group and 75% were fused in the BL group. 
 Fig. 2. Graph of mean with quartiles marked of rabbit manual palpation scores (Top) across the weeks evaluated. 
Rabbits with unilateral and bilateral decortications and bone grafting were combined for graphic purposes 
because there was no statistically significant difference in the score for these two groups (0=no fusion and no 
reduction in motion, 1=minimal, 2=mild, 3=moderate reduction of motion and limited movement, and 4=marked 
reduction of motion or no movement at the level of interest compared with adjacent levels). Of note, at Weeks 1, 
2, 6, and 10, all manual palpation scores were the same. Graph of mean and quartiles of radiographic scores 
(Bottom) across the weeks evaluated. Scores for only decortication and bone graft sites were included. All other 
groups were scored 1 (1=no fusion, 2=partial fusion, and 3=completely fused). At Week 2, all radiographic scores 
were 1, and at Week 10, all radiographic scores were 3. Data show a linear increase in score for manual palpation 
and radiographic assessments of spine fusion that plateaus sometime between 5 and 6 weeks. 
Radiographic scores significantly increased with time, reaching a plateau at 6 weeks (Fig. 2). 
Radiographic imaging over the weeks of spine fusion (Fig. 3A–H) showed no signs of radiographic fusion 
at 2 weeks, but bone graft could be identified at sites of decortication and bone grafting. (Fig. 3A and B). 
Radiographic fusion was seen in nearly all decortication and bone graft sites (83.33%) by Week 6 and in 
0% of the interpositional fat graft sites (Fig. 3F) in all UL rabbits out to 10 weeks. Radiographic scores 
increased over time, representing radiographic evidence of progressive fusion (p<.0003) in decorticated 
and bone graft sites only. At Week 10, all decorticated and bone-grafted sites had a radiographic score 
indicating fusion. (Fig. 3G and H). 
 Fig. 3. Dorsal-ventral radiographs of rabbit lumbar spines with bilateral decortication and bone graft (left column) 
and unilateral decortication and bone graft on one side with interpositional fat graft on the contralateral side (right 
column). At 2 weeks, bone graft can be seen bilaterally (A) and unilaterally (B) without bony bridging. The 
interpositional fat graft obviated fusion between transverse processes (arrow in B). There was no significant 
lucency within the bone graft and evidence of further consolidation of the fusion mass between transverse 
processes in radiographs at 4 weeks in C and D. (E and F) Radiographs from rabbits at 6 and 10 postoperative 
weeks, respectively. There was a significant bony growth with developing cortical and trabecular bones between 
transverse processes by Week 10 (G and H). 
Histology of the fusion mass 
Bone autograft resorption and endochondral ossification was seen at 2 weeks (Fig. 4A). Cartilage had 
formed directly adjacent to autograft fragments within the intertransverse process space. The amount 
of endochondral ossification and new bone formation was minimal (Fig. 4B). At 4 weeks, greater osteoid 
(Fig. 4C) was present within the intertransverse process space, directly adjacent to the autograft. Bone 
had grown within the intertransverse process space and was in the process of developing lamellar bone 
by Week 4 (Fig. 4C and D). 
 
Fig. 4. (A) Micrograph from the intertransverse process space from a UL-treated rabbit at 2 postoperative weeks 
showing a focus of endochondral ossification (white circle) directly adjacent to an unincorporated bone graft 
fragment with empty lacunae (white arrow) (H&E, original magnification=79×). (B) Macroscopic sagittal histology 
image of the intertransverse process space from a UL-treated rabbit at 2 postoperative weeks showing 
unincorporated bone graft fragments within the intertransverse process space at 2 postoperative weeks (H&E, 
either a millimeter scale in the field or 4×). (C) Micrograph from the intertransverse process space from a UL-
treated rabbit at 4 postoperative weeks showing a trabecular pattern of de novo bone dorsal to the decorticated 
transverse process (H&E, original magnification=79×). (D) Macroscopic sagittal histology image of the 
intertransverse process space from a BL-treated rabbit at 4 postoperative weeks showing the development of a 
bony fusion mass with the incorporation of bone autograft fragments dorsal to and between the decorticated 
transverse processes (white arrows) at 4 postoperative weeks (H&E, millimeter scale in the field). UL, unilateral 
fusion; H&E, hematoxylin and eosin; BL, bilateral fusion. 
The fusion mass continued to mature at 6 and 10 weeks (Fig. 5A–D) as demonstrated by consolidating 
bone with the incorporation of the autograft fragments. There was evidence of osteoblasts facilitating 
bone growth (Fig. 5A). By 10 weeks, bone growth and maturation resulted in a de novo fusion mass 
(Fig. 5C and D). A cement line was found between the autograft and newly formed de novo bone. 
Histology confirmed substantial bone growth and maturation of the fusion mass that coincided with loss 
of spine mobility as assessed by a manual palpation score. There was a greater amount of de novo bone 
formation within the 4- and 6-week groups as compared with the 10-week group. This result may reflect 
the normal coupling of bone formation and bone remodeling that results in a smaller final bone callous 
volume.40,41 
 Fig. 5. (A) Micrograph from a BL-treated rabbit at 6 postoperative weeks showing hypertrophied osteoblasts and 
several foci of intramembranous ossification. Bone autograft fragments (with empty osteocyte lacunae) are 
incorporated into the developing fusion mass within the intertransverse process space at 6 postoperative weeks 
(H&E, original magnification=125×). Macroscopic sagittal histology image (B) of the intertransverse process space 
from a UL-treated rabbit at 6 postoperative weeks showing substantial bony growth and the development of a 
bony fusion mass with the incorporation of bone autograft fragments dorsal to and between the decorticated 
transverse processes (white arrows) at 6 postoperative weeks (MAB, millimeter scale in the field). Micrograph (C) 
from a BL-treated rabbit at 10 postoperative weeks showing hypertrophied osteoblasts and foci of 
intramembranous ossification. Bone autograft fragments (with empty osteocyte lacunae) are incorporated into the 
developing fusion mass within the intertransverse process space at 10 postoperative weeks. A cement line is 
observed between autograft and newly formed de novo bone (white arrow) (H&E, original magnification=79×). (D) 
Macroscopic sagittal histology image of the treated intertransverse process space from a BL-treated rabbit at 10 
postoperative weeks showing the development of a bony fusion mass with the incorporation of bone autograft 
fragments dorsal to and between the decorticated transverse processes (white arrows) (MAB, millimeter scale in 
the field). H&E, hematoxylin and eosin; BL, bilateral fusion. 
Quantitative RT-PCR 
The results of RT-PCR adipokine gene expression are presented as (2^ΔCt) in Fig. 6A–D. There were no 
significant differences in gene expression between bone from two levels cephalad to the level of interest 
in the BL and UL groups, bone from the level of interest in control rabbits, and bone from the 
contralateral non-fused side at the level of interest in the UL group (p>.05), indicating representation of 
a non-fusing bone. We selected the interpositional fat graft procedure as the control comparison to the 
decortication and bone graft fusion mass for illustrative purposes for PCR data, but results did not differ 
when decortication and bone graft data were compared with sham control or adjacent spine levels. 
Expression of adiponectin, resistin, VEGF, and leptin within the decortication and bone graft fusion mass 
showed significant (p<.05) time-dependent changes corresponding to different histologic findings, 
radiographic results, and manual palpation scores at different time points (Fig. 6A–D). There were no 
significant changes in leptin, VEGF, resistin, or adiponectin within the control interpositional fat graft 
mass, indicating that these variations in gene expression of these adipokines was bone fusion specific. 
Leptin increased during the 3- to 6-week time frame, spiking at 5 weeks. This finding corresponded to 
increased bone formation, incorporation of bone graft, and development of woven bone between 
transverse processes (Fig. 4, Fig. 5). The timing of this increase in leptin corresponded to the 
incorporation of bone graft with the remodeling of the fusion mass. 
Adiponectin expression was greatest 1 week after surgery only in the sites receiving decortication and 
bone graft (Fig. 6B). This corresponded to the initial reactive phase to bone graft and the decortication 
procedure. Adiponectin expression decreased by 2 weeks and no longer differed from the control 
interpositional fat graft site for the rest of the study. 
Resistin expression decreased during the middle, reparative phase of the spinal fusion. There was a 
mixture of woven and lamellar bones developing between transverse processes during these time 
periods (Fig. 4, Fig. 5). At 6–10 weeks, resistin returned to Week 1 levels as the fusion mass matured. 
Vascular endothelial growth factor expression had two peaks of expression at Weeks 4 and 10, which 
were significantly greater than the control sites (p<.05). These time points corresponded to 
histopathology findings that had bone development as the dominant tissue activity (Fig. 5A and B). 
Normalization of adipokine expression to the control rabbit's bone at Week 2 (ΔΔCt) demonstrated a 
similar pattern to the changes in gene expression across time for leptin, adiponectin, vascular 
endothelial growth factor A, and resistin (Fig. 7). Specifically, 1.0 was equivalent to baseline expression 
from control rabbits. As in the ΔCt data (Fig. 6), leptin downregulated over the first 2 weeks and 
increased during the bone formation phase between Weeks 3–5. The increase and the decrease in VEGF 
expression occurred just after the increase in leptin and after the decrease in leptin, respectively. 
 Fig. 6. Illustrations of mean±standard error of the mean gene expression differences in the threshold cycle (2^ΔCt) 
number between the target gene and the internal control reference gene, GAPDH. Means without a common 
superscript letter differ (p<.05), as analyzed by one-way analysis of variance of leptin (A), adiponectin (B), resistin 
(C), and VEGF (D). Leptin starts to increase at Week 3, significantly spiking at Week 5. The increase in leptin occurs 
just before a significant spike in VEGF expression at Week 4. Both resistin and adiponectin spike in expression 
during the initial stage of healing at Week 1. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; VEGF, vascular 
endothelial growth factor. 
 Fig. 7. Mean fold change in leptin, adiponectin, resistin, and VEGF-A gene expression standardized to the control 
sham surgery group using the 2(−ΔΔCt) method. Note the uptick in leptin expression that is upstream from an 
increase in vascular endothelial growth factor. There is a substantial increase in leptin expression by Week 5. Also, 
the same trends in Fig. 6 are reflected in the patterns of mean fold expression shown in this figure. This includes 
the increase in adiponectin and resistin in the initial week of healing. VEGF-A, vascular endothelial growth factor A. 
Discussion 
Our study showed significant patterns of adipokine gene expression unique to each adipokine, which 
varied during the spinal fusion process. Leptin expression spiked within the fusion mass during the bony 
remodeling phase at 3–6 weeks. Adiponectin expression contrastingly is relatively greater initially during 
the reactive phase and decreases dramatically shortly thereafter. When comparing expression profiles, 
there was evidence that the expression of leptin is upstream to that of VEGF, given that the increases in 
leptin occurred just before the increases in VEGF expression. These findings are consistent with previous 
research on the role of leptin within bony healing.11,42,43,44,45 Our data support this importance of leptin 
for bony healing phases of spinal fusion. The results of our experiment were consistent with our initial 
hypothesis in that leptin and VEGF expression increased during the remodeling phase of callus formation 
for the spinal fusion process. Results related to the differing expression of adiponectin and resistin, 
however, were unexpected given that these adipokines increased initially during the inflammatory 
phase of healing and only rose again during the final late or remodeling phase for the fusion mass. 
Our results indicate that adipokine expression varies significantly during the spinal fusion process. As 
mentioned previously, there is an established link between adipokines and the low-grade inflammatory 
state of obesity.15,16 Therefore, the change in normal homeostasis of adipokine expression at the local 
and systemic level for obese patients might contribute to the poor clinical outcomes for the obese 
population.46,47,48 Further research is needed to determine how adipokine expression at the local or 
systemic level changes for obese patients undergoing spinal fusion surgery and how these changes 
might affect clinical outcomes. 
The coordinated expression profile of leptin and VEGF suggested that these factors are connected. The 
high expression of VEGF within the bony remodeling phase of healing as well as the final remodeling 
phase of healing (at 10 weeks) has been demonstrated in previous studies.49,50 Leptin has been shown to 
increase the expression of the VEGF and the VEGF receptor on mouse mammary cancer cells.27 Although 
we did find in vitro reports on the impact of leptin on the VEGF or the VEGF receptor within a fusion 
mass, our data suggested that this same upstream position of leptin might exist in vivo for bony healing. 
We found that VEGF expression was more transient than leptin, as it decreased after the initial spike in 
leptin. Leptin, therefore, may trigger angiogenesis in spinal fusion, as during fracture healing.51 
Adiponectin expression during the initial reactive response to decortication and bone grafting decreased 
after Week 1, with a significantly greater decrease than in the interpositional fat graft sites, and our data 
suggested this drop might be linked to initial bone healing. Previous research has shown contrasting 
results in terms of the effect of adiponectin on bone remodeling.52,53,54,55,56 There was a complex role of 
adiponectin in bone healing, and the impact of adiponectin may depend on the timing and the amount 
of the adiponectin activity.52,55 Our results suggested that local expression of adiponectin might precede 
initial bone reaction during the inflammatory phase of spinal fusion and might be downregulated during 
the growth of a spinal fusion mass. 
Our study has several limitations. We were forced to use GAPDH as a housekeeping gene as a control 
because of our inability to find the correct primer sequence for New Zealand white rabbits for either 18s 
rRNA or beta-actin mRNA. The authors acknowledge that there may be a variation in the expression of 
GAPDH that could have influenced our results as has been mentioned in previous literature.57,58 We used 
the manual palpation examination to assess spinal fusion. Although previous research has demonstrated 
the validity of this examination, we acknowledge the subjective nature of this outcome.29,35 In addition 
to this assessment, we provided radiographic and histologic assessments of bone remodeling. 
Our study goal was to measure the variations and patterns of adipokine expression with bone fusion of 
the spine. To assist with this goal, we normalized our data by several methods, and our results showed 
similar findings with each of the control comparisons. One comparison for analysis was bone from sham 
control rabbits at 2 weeks to UL and BL groups, serving to control for general anesthesia and skin 
incision with muscle dissection. Another comparison for analysis was the lumbar sites cephalad and 
caudal to L5 and L6 to control for time effects in healthy bone on these same rabbits. The last 
comparison for analysis was the interpositional fat graft site at the L5–L6 lumbar space, which provided 
comparative information for the effect of soft-tissue injury, tissue grafting, and, potentially, the 
retention of limited motion at a surgical site on the adipokine gene expression profile. Given that 
changes in leptin, adiponectin, resistin, and VEGF were only seen in the decortication and bone fusion 
masses, it followed that these fluctuations in gene expression were likely associated with the bone 
fusion process. Future research will be required to examine adipokine expression during the human 
spinal fusion process and whether strategic influence through adipokine pathways could be effective in 
accelerating this process. There are still many unanswered questions about the precise interplay of 
adipokines and bone healing in general and in spinal fusion in particular. We hope our results encourage 
research into this topic. 
In summary, our study reported the temporal changes in expression of adipokines during spinal fusion. 
Leptin is likely associated with the maturation phase of bone fusion at 3–6 weeks and may play a role in 
promoting this process as in fracture healing. Adiponectin is associated with the bone reactive and 
inflammatory phase of bony fusion and may play a role early on in the fusion process. Vascular 
endothelial growth factor expression was temporally associated with leptin expression. This evidence 
supported the hypothesis that leptin expression may be upstream of VEGF expression during spinal 
fusion. Future research would be required to understand the cascade and interdependence of adipokine 
expression within the spinal fusion process in humans. Furthermore, these results underscore the varied 
physiological roles that white adipose tissue plays in bone metabolism through adipokines. 
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